Commodore Capital

Company

Investment-firm

Financing round

General

About Company
Commodore Capital partners with biopharmaceutical companies to develop medical products that improve patients' lives.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2019

IPO status

Private

Description

With a science-driven approach, Commodore Capital invests in small-cap public and late-stage private biopharmaceutical companies during the early stages of a major innovation cycle in the industry. Founded in 2019 by Egen Atkinson, the firm aims to support these companies as they bring safe and effective new medicines to patients worldwide.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
MPM Capital

MPM Capital

MPM Capital invests in early-stage healthcare companies developing innovative oncology technologies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Cambridge, MA, USA

count Of Investments

212

count Of Exists

66
Arcus Ventures

Arcus Ventures

Arcus Ventures is a private equity firm that invests in oncology-focused companies with advanced biopharmaceuticals.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Venture Capital, Biotechnology

Location

New York, NY, USA

count Of Investments

23

count Of Exists

3
Meneldor

Meneldor

Meneldor is a venture capital firm that allows customers to invest in early stage biotech and pharma companies alongside specialists.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology

Location

Druten, Netherlands

count Of Investments

6
Cell Innovation Partners

Cell Innovation Partners

Japanese venture capital firm, Cell Innovation Partners, focuses on investing in stem cell and regenerative medicine companies.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Venture Capital, Financial Services

Location

Fukushima, Japan

count Of Investments

1

Financials

Investments
26
Date 
name 
Lead 
type 
Raised 
Avalo Therapeutics

Avalo Therapeutics

Avalo Therapeutics is a clinical-stage biopharmaceutical company that develops highly targeted therapeutics for unmet clinical needs.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Rockville, MD, USA

total rounds

3

total raised

$231.5M
Nkarta Therapeutics

Nkarta Therapeutics

Nkarta Therapeutics develops potent and safer cell therapies for cancer treatment.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

South San Francisco, CA, USA

total rounds

4

total raised

$595M
Enliven Therapeutics

Enliven Therapeutics

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Boulder, CO, USA

total rounds

5

total raised

$395M
Co-Investors

People

Employee Profiles
3
Michael Kramarz

Michael Kramarz

Co-Founder & Managing Partner

Robert Glass

Chief Financial Officer

Egen Atkinson

Egen Atkinson

Co-Founder & Managing Partner

Activity

Recent News
5
News Timeline

The graph reveals the ratio (%) of positive news articles in a chosen time range

month